Lilly tight-lipped over WHO Foundation dementia deal
US drugmaker Lilly has refused to disclose the amount it is giving as part of a dementia deal with the WHO Foundation. The company announced…
Bavarian Nordic’s troubled takeover bid gets EU clearance
The European Commission has approved a private equity takeover bid for Bavarian Nordic, the Danish maker of vaccines for mpox, cholera and chikungunya, leaving disgruntled…
Valneva extends loans after chikungunya jab concerns
Vaccine specialist Valneva has refinanced its debt and cut its revenue forecast for this year after the US FDA suspended the licence for its chikungunya…
Former New Zealand PM appointed chair of Gavi
Helen Clark, the former prime minister of New Zealand, has been appointed as chair of Gavi, the Vaccine Alliance, as the global vaccine group refocuses…
Chikungunya to spread beyond tropical regions, machine learning predicts
A new model which uses machine learning to forecast the spread of chikungunya has predicted that the mosquito-borne virus will spread much further than expected,…
GSK announces COO Miels as next CEO
GlaxoSmithKline has announced that its current chief operating officer Luke Miels would take over as chief executive. The company, one of the world’s biggest drugmakers,…
Pakistan launches HPV campaign
Pakistan has become the latest country to launch a vaccination campaign against Human Papillomavirus (HPV) to protect adolescent girls from cervical cancer in later stages…
More cholera vaccines needed – WHO
Donors and governments need to invest more in vaccines against cholera, the WHO said, as the latest data show an increase in deaths from the…
World off-track to meet health SDGs – WHO
The World Health Organization (WHO) Results Report 2024 shows that the world is off track to meet the health-related SDGs, amid a darkening geopolitical outlook for…
Uganda launches largest-ever malaria vaccine drive
Uganda has started the world’s biggest malaria vaccination campaign as the East African country battles one of the highest global incidences of the disease. On…